Log In
Print this Print this

Bioabsorbable Cardiac Matrix (BCM) device (BL-1040, IK-5001)

  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionBiodegradable injectable liquid polymer designed to support damaged heart tissues following a myocardial infarction (MI)
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentPivotal
Standard IndicationMyocardial infarction (MI)
Indication DetailsPrevent deterioration of the myocardium following myocardial infarction (MI); Prevent ventricular remodeling and congestive heart failure (CHF) following acute myocardial infarction
Regulatory Designation


Bellerophon Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today